Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers.
Anal
Biliary
Canal anal
Cancer
Estomac
Gastric
Hépatocarcinome
Irradiation stéréotaxique
Liver
Metastasis
Métastase
Oesophageal
Oligometastasis
Oligométastase
Pancreatic
Pancréas
Rectal
Rectum
Stereotactic body radiotherapy
Synchrone
Synchronous
Voies biliaires
Œsophage
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
06 Oct 2023
06 Oct 2023
Historique:
received:
09
02
2023
revised:
27
03
2023
accepted:
07
04
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
8
10
2023
Statut:
aheadofprint
Résumé
Metastatic gastrointestinal cancer is not an uncommon situation, especially for pancreatic, gastric, and colorectal cancers. In this setting, few data are available on the impact of the treatment of the primary tumour. Oligometastatic disease is associated with longer survival in comparison with more advanced disease. Metastasis-directed therapy, such as stereotactic body radiotherapy, seems related to better outcomes, but the level of evidence is low. In most tumour locations, prospective data are very scarce and inclusion in ongoing trials is strongly recommended.
Identifiants
pubmed: 37806823
pii: S1278-3218(23)00209-3
doi: 10.1016/j.canrad.2023.04.007
pii:
doi:
Types de publication
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.